Evidence map›Paper›PMID 33392843›Full record

ArticleBreast cancer research and treatment2021

Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis.

AnnaLynn M Williams, Carly Paterson Khan, Charles E Heckler, Debra L Barton, Mary Ontko, Jodi Geer, Amber S Kleckner, Shaker Dakhil, Jerry Mitchell, Karen M Mustian and 5 more

Open access · greenAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 87 citations in OpenAlex.

  1. Pooled it
  2. Music Therapy Versus Cognitive Behavioral Therapy via Telehealth for Anxiety in Survivors of Cancer: A Randomized Clinical Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
    Trial
  3. Trial
  4. A machine learning approach to profiling anxiety risk among cancer patients on treatment.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Effects of oral intake, symptom severity, and sex difference on cancer patient prognosis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 1 country.

AnnaLynn M WilliamsUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA. AnnaLynn.Williams@stjude.org.ORCID http://orcid.org/0000-0002-7042-5851
Carly Paterson KhanPatient-Centered Outcomes Research Initiative, Rochester, USA.
Charles E HecklerUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA.
Debra L BartonSchool of Nursing, University of Michigan, Ann Arbor, USA.
Mary OntkoDayton Clinical Oncology Program, Dayton, USA.
Jodi GeerMetro Minnesota Community Oncology Research Program, St Louis Park, USA.
Amber S KlecknerUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA.
Shaker DakhilWichita NCORP, Wichita, USA.
Jerry MitchellColumbus NCORP, Columbus, USA.
Karen M MustianUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA.
Luke J PepponeUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA.
Victor KipnisNational Cancer Institute, Bethesda, USA.
Charles S KamenUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA.
Ann M O'MaraNational Cancer Institute, Bethesda, USA.
Michelle C JanelsinsUniversity of Rochester Medical Center, James P. Wilmot Cancer Institute, St. Jude Children's Research Hospital, Rochester, USA. michelle_janelsins@urmc.rochester.edu.
St. Jude Children's Research Hospital · USNational Cancer Institute · USDayton Clinical Oncology Program · USMetro-Minnesota Community Oncology Research Consortium · USPatient-Centered Outcomes Research Institute · USUniversity of Michigan · USUniversity of Rochester Medical Center · USWichita Clinic · US

Funding

URCC NCORP Research BaseUG1CA189961 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, KAREN M. MUSTIAN · 2014 to 2026
$67.7M
Translational Neuroscience Approaches to Cancer-Related Cognitive Impairment: Measurement, Mechanisms, and FunctionR01CA231014 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C · 2019 to 2024
$3.1M
Clinical and Translational Cancer Control Research Training ProgramT32CA102618 · NCI · UNIVERSITY OF ROCHESTER · PI Michelle C Janelsins, Gary R Morrow · 2019 to 2026
$2.7M
Clinical and Translational Approaches to Cognitive Impairments in CancerDP2CA195765 · NCI · UNIVERSITY OF ROCHESTER · PI JANELSINS, MICHELLE C · 2014 to 2014
$2.3M
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivorsK00CA222742 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI WILLIAMS, ANNALYNN · 2019 to 2020
$180k
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivorsF99CA222742 · NCI · UNIVERSITY OF ROCHESTER · PI WILLIAMS, ANNALYNN · 2017 to 2018
$67k
NCI NIH HHS DP2 CA195765NCI NIH HHS F99 CA222742NCI NIH HHS F99CA222742NCI NIH HHS K00 CA222742NCI NIH HHS R01 CA231014NCI NIH HHS R01CA231014NCI NIH HHS T32 CA102618NCI NIH HHS UG1 CA189961NIH HHS DP2CA195765
6 · The paper itself

Abstract

purposeFatigue and anxiety are common and significant symptoms reported by cancer patients. Few studies have examined the trajectory of multidimensional fatigue and anxiety, the relationships between them and with quality of life.

methodsBreast cancer patients (n = 580) from community oncology clinics and age-matched controls (n = 364) completed fatigue and anxiety questionnaires prior to chemotherapy (A1), at chemotherapy completion (A2), and six months post-chemotherapy (A3). Linear mixed models (LMM) compared trajectories of fatigue /anxiety over time in patients and controls and estimated their relationship with quality of life. Models adjusted for age, education, race, BMI, marital status, menopausal status, and sleep symptoms.

resultsPatients reported greater fatigue and anxiety compared to controls at all time points (p's < 0.001, 35% clinically meaningful anxiety at baseline). From A1 to A2 patients experienced a significant increase in fatigue (β = 8.3 95%CI 6.6,10.0) which returned to A1 values at A3 but remained greater than controls' (p < 0.001). General, mental, and physical fatigue subscales increased from A1 to A2 remaining significantly higher than A1 at A3 (p < 0.001). Anxiety improved over time (A1 to A3 β =  - 4.3 95%CI -2.6,-3.3) but remained higher than controls at A3 (p < 0.001). Among patients, fatigue and anxiety significantly predicted one another and quality of life. Menopausal status, higher BMI, mastectomy, and sleep problems also significantly predicted change in fatigue.

conclusionBreast cancer patients experience significant fatigue and anxiety up to six months post-chemotherapy that is associated with worse quality of life. Future interventions should simultaneously address anxiety and fatigue, focusing on mental and physical fatigue subdomains.

Indexed as

Breast NeoplasmsQuality of LifeAnxietyDepressionFatigueFemaleHumansMastectomyAnxietyBreast cancerFatigueSurvivorshipSymptom management

Identifiers

PMID33392843
PMCPMC8080260
OpenAlexW3119677422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.